![](https://www.myesr.org/app/uploads/2023/10/fig-9-768x510.jpg)
Combining molecular and imaging metrics in cancer: radiogenomics
In oncology, we are in the era of personalized medicine that enables increasingly precise, often molecular-based approaches (genomics, transcriptomics, proteomics, metabolomics, etc.) to disease treatments and prevention strategies for our patients. Molecular testing remains expensive, invasive, and time-consuming, and thus unavailable for all patients. In addition, invasive tumor sampling only provides a snap-shot of often heterogeneous tumors and is not